Literature DB >> 29204622

Dyslipidemia.

Laurie Kopin1, Charles Lowenstein1.   

Abstract

Dyslipidemia is an important risk factor for coronary artery disease and stroke. Long-term, prospective epidemiologic studies have consistently shown that persons with healthier lifestyles and fewer risk factors for coronary heart disease, and particularly those with favorable lipid profiles, have reduced incidence of coronary heart disease. Prevention and sensible management of dyslipidemia can markedly alter cardiovascular morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29204622     DOI: 10.7326/AITC201712050

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  102 in total

1.  Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a Chinese tertiary care hospital.

Authors:  Zi Guo; Chun Yue; Qiang Qian; Honghui He; Zhaohui Mo
Journal:  Int Wound J       Date:  2019-08-25       Impact factor: 3.315

2.  Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review.

Authors:  Aladeen Alloubani; Refat Nimer; Rama Samara
Journal:  Curr Cardiol Rev       Date:  2021

3.  State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Authors:  Kaleen M Lavin; Paul M Coen; Liliana C Baptista; Margaret B Bell; Devin Drummer; Sara A Harper; Manoel E Lixandrão; Jeremy S McAdam; Samia M O'Bryan; Sofhia Ramos; Lisa M Roberts; Rick B Vega; Bret H Goodpaster; Marcas M Bamman; Thomas W Buford
Journal:  Compr Physiol       Date:  2022-03-09       Impact factor: 8.915

4.  Blood pressure variability at different time periods within first 24 hours after admission and outcomes of acute ischemic stroke.

Authors:  Xuyang Geng; Xinyao Liu; Fang Li; Jiamin Wang; Hongwei Sun; Anqi Feng; Yanyan Sun; Hongwei Sun; Fan Yang; Jingbo Zhao; Ying Tang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

5.  Association of meat consumption with NAFLD risk and liver-related biochemical indexes in older Chinese: a cross-sectional study.

Authors:  Hewei Peng; Xiaoxu Xie; Xinting Pan; Jing Zheng; Yidan Zeng; Xiaoling Cai; Zhijian Hu; Xian-E Peng
Journal:  BMC Gastroenterol       Date:  2021-05-17       Impact factor: 3.067

6.  A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed-dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension.

Authors:  Woohyeun Kim; Kiyuk Chang; Eun Joo Cho; Jeong-Cheon Ahn; Cheol Woong Yu; Kyoung-Im Cho; Yong-Jin Kim; Duk-Hyun Kang; Seok-Yeon Kim; Sang-Hak Lee; Ung Kim; Shin-Jae Kim; Young Keun Ahn; Chang Hoon Lee; Jin Ho Shin; Mikyung Kim; Chang Gyu Park
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-31       Impact factor: 3.738

7.  Preclinical Pharmacokinetics and Pharmacodynamics of Coptidis Preparation in Combination with Lovastatin in High-Fat Diet-Induced Hyperlipidemic Rats.

Authors:  Wen-Ya Peng; Andy C Huang; Chin-Tsung Ting; Tung-Hu Tsai
Journal:  ACS Omega       Date:  2021-06-10

8.  A Model for Risk Prediction of Cerebrovascular Disease Prevalence-Based on Community Residents Aged 40 and above in a City in China.

Authors:  Qin Zhu; Die Luo; Xiaojun Zhou; Xianxu Cai; Qi Li; Yuanan Lu; Jiayan Chen
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

9.  Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease.

Authors:  Vincent J H Yao; Michael Sun; Aivi A Rahman; Zachariah Samuel; Joyce Chan; Elizabeth Zheng; Alan C Yao
Journal:  Clin Exp Hepatol       Date:  2021-06-30

10.  Effect of onion on blood lipid profile: A meta-analysis of randomized controlled trials.

Authors:  Wang Huang; Gang Tang; Linyu Zhang; Jie Tao; Zhengqiang Wei
Journal:  Food Sci Nutr       Date:  2021-05-13       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.